Stonepine Capital Management, LLC 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:00 pm Sale | 2025-12-31 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Stonepine Capital Management, LLC | 156,179 2.100% | -221,061 (-58.60%) | Filing |
| 2025-09-08 5:44 pm Purchase | 2025-09-02 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Stonepine Capital Management, LLC | 377,240 5.200% | 377,240 (New Position) | Filing |